Recent

% | $
Quotes you view appear here for quick access.

Optimer Pharmaceuticals, Inc. (OPTR) Message Board

  • carylindsay1443@sbcglobal.net carylindsay1443 Nov 3, 2011 6:04 PM Flag

    The 'Weasel' Says Measely!

    Sure the numbers presented in Q report were 'measely', but considering there were 10 analyst that had projections for the report with the average estimates of revenue coming in at $5.44Million only to have OPTER blow through that number by nearly 100% to the upside.
    Maybe the astute weasel needs to climb back into his hole because Punxsutawney Phil predicts he will rue the day he stuck his head out today! I see sunshine!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'm long 1000 shares.

      I gather than revenue is twice what was predicted, but that outlay and overhead were 10% more than predicted. Am I right to understand that a loss per share WAS expected?

      If a loss was expected, and if revenue doubled expectations, why wouldn't the prognosis be very good? The product is good. It just cost more to market than expected, but that expense won't be repeated, right? So, q4 should be almost all revenue, right?

      • 1 Reply to chillpillory
      • mikeadd@bellsouth.net mikeadd Nov 3, 2011 6:48 PM Flag

        CP, cost will most always be higher than revenues when starting a business or new product no matter what type company it is as I'm sure you know. The problem as I see it is that the sales/scrips written were basiclly flat from last quarter to this one: I believe there were 886 last quarter to 1400 this quarter and there were 5 weeks in this quarter. Bottom line is that expectations were for a very good quarter and we all had high expectations based on available information. So, to me, we're still good; just gonna take a little more time to be realized.

 
OPTR
12.780.0000(0.00%)Oct 23 4:00 PMEDT